Aethlon receives approval to begin Hemopurifier study at Sarcoma Oncology Center

[News]

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumor-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California.

More... (http://www.news-medical.net/news/20111207/Aethlon-receives-approval-to-begin-Hemopurifier-study-at-Sarcoma-Oncology-Center.aspx)